Clinical trial results further confirmed that in patients with advanced pancreatic cancer, the expression levels of NF-κB, COX-2, and STAT3 in peripheral blood mononuclear cells (PBMCs) were significantly reduced following curcumin treatment [93]. The gene discussed is MTCO2P12; the disease is familial pancreatic carcinoma.